Canada Pension Plan Investment Board
AVXL icon

Canada Pension Plan Investment Board’s Anavex Life Sciences AVXL Stock Holding History

Canada Pension Plan Investment Board’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$523K Buy
201,800
+63,500
+46% +$188K ﹤0.01% 1248
2026
Q1 		$425K Buy
138,300
+42,400
+44% +$184K ﹤0.01% 1291
2025
Q4 		$341K Buy
+95,900
New +$588K ﹤0.01% 1462

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Canada Pension Plan Investment Board's AVXL Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Anavex Life Sciences (AVXL) stake by 46% in Q2 2026, buying an estimated $188K and bringing the position to 201,800 shares worth $523K. The position accounts for ﹤0.01% of the portfolio, ranked #1248.

Canada Pension Plan Investment Board first reported a position in AVXL in Q4 2025 and has held it in 3 quarters since. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Canada Pension Plan Investment Board held 201,800 shares of Anavex Life Sciences worth $523K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 63,500 Anavex Life Sciences shares in Q2 2026, an estimated $188K.
  • Anavex Life Sciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1248 holding.
  • Canada Pension Plan Investment Board first reported a position in Anavex Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.